Table 1. Clinicopathological characteristics of skin tumors.
| BCC (n = 81) | TE (n = 16) | SCC (n = 17) | MN (n = 5) | PMC (n = 10) | EP (n = 11) | HDA (n = 9) | SPA (n = 10) | |
|---|---|---|---|---|---|---|---|---|
| Sex | ||||||||
| Male (%) | 29 (36) | 3 (19) | 7 (41) | 4 (80) | 2 (20) | 6 (55) | 2 (22) | 5 (50) |
| Female (%) | 52 (64) | 13 (81) | 10 (59) | 1 (20) | 8 (80) | 5 (45) | 7 (78) | 5 (50) |
| Age (years) | ||||||||
| Mean (s.d.) | 75 (13) | 49 (19) | 69 (15) | 64 (15) | 9.8 (4.3) | 56 (20) | 44 (21) | 54 (11) |
| Range | 24–94 | 6–71 | 33–93 | 49–83 | 3–18 | 28–82 | 2–68 | 36–69 |
| Tumor size (cm) | ||||||||
| Mean (s.d.) | 1.0 (0.8) | 1.2 (1.3) | 1.8 (1.4) | 4.3 (2.1) | 1.7 (0.5) | 1.3 (0.5) | 1.5 (0.6) | 1.3 (0.7) |
| Range | 0.2–5.3 | 0.5–4.0 | 0.4–6.0 | 1.8–7.0 | 1.0–2.5 | 0.8–2.0 | 0.8–2.2 | 0.4–2.7 |
Abbreviation: BCC, Basal cell carcinoma; TE, trichoepithelioma; SCC, squamous cell carcinoma; MN, malignant melanoma; PMC, pilomatricoma; EP, eccrine poroma; HDA, hidradenoma, SPA, spiradenoma, s.d., standard deviation